Otsuka Electronics has gained Food and Drug Administration clearanceto sell its OE 1.5 SI MRI system in the U.S. (SCAN 12/25/91 and2/11/92). The Fort Collins, CO, company was notified about theFDA action July 20. Its 510(k) application was submitted
Otsuka Electronics has gained Food and Drug Administration clearanceto sell its OE 1.5 SI MRI system in the U.S. (SCAN 12/25/91 and2/11/92). The Fort Collins, CO, company was notified about theFDA action July 20. Its 510(k) application was submitted Feb.5.
The first 1.5-tesla unit will be installed at Barnes West Hospitalin St. Louis, said Dale Grant, Otsuka marketing vice president.The service is a collaboration between the hospital and MallinckrodtInstitute, also in St. Louis. Other shipments will begin in September,Grant said.
The price and design of the OE 1.5 SI system attracted attentionwhen the Japanese-owned company introduced the product at lastyear's RSNA conference. The $1.2 million system is the lowestpriced high-field product sold in the U.S. market. It is alsothe only superconducting system in the current generation of MRIsystems to depart from whole-body scanning. The design featuresremovable gradient and radio-frequency coils dedicated to specificapplications.
Engineering problems with its innovative flat gradient coilsfor spinal and shoulder applications recently forced changes tothe system's configuration. The company set aside the flat gradientapproach in favor of a cylindrical large-volume gradient. As withthe head and extremity coil, the large-volume gradient is removable.
The company backed away from the flat gradient design whenprototypes powerful enough to produce adequate fields of viewproved to be too large for the magnet, Grant said.
Otsuka has not abandoned the approach, however. "We aregoing to continue to work toward an efficient flat gradient systembecause it seems to have a lot of flexibility and potential,"Grant said.
On the plus side, the announcement that Otsuka's first systemwill be installed at a Mallinckrodt-affiliated facility indicatesluminary sites are willing to conduct research with the equipment.
Gaining access to top-flight centers has been no small taskfor Otsuka. In January, the prestigious Barrow Research Institutein Phoenix reneged on a commitment to experiment with the OE system.Officially, Barrow backed away because the facility was overloadedwith projects. Another factor in Barrow's decision, however, mayhave been a threat by GE to withdraw its research support fromthe institute, according to industry sources.
This identical scenario was apparently played out at two otherhigh-profile facilities.
"GE scared a couple away," Grant acknowledged.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.